October 20, 2021
Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO
Oslo, Norway, 20 October 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today ...
Read more
Read more
October 19, 2021
Germany is world’s first country to cover digital therapeutic for Burnout through universal reimbursement – free access for 50 million adults
Berlin/Hamburg, 19 October 2021 – The digital therapeutic HelloBetter Stress and Burnout has been permanently approved by the Federal Institute for Drugs and Medical D...
Read more
Read more
October 19, 2021
Nordic Nanovector enters research collaboration with the University of Pennsylvania to generate a novel CD37-targeting CAR-T cell approach
Oslo, Norway, 19 October 2021
Nordic Nanovector ASA (OSE: NANOV) is pleased to announce that it has entered into a research collaboration with the University of Penns...
Read more
Read more
October 12, 2021
Lakeside is the first healthcare provider in the UK to go live with the Doctrin platform – the second generation of digital healthcare systems from the Swedish healthtech company Doctrin
Doctrin – a Swedish healthtech company – has for the last five years proven its ability to transform access to and delivery of care, care continuity, patient experience and ef...
Read more
Read more
October 7, 2021
Aro Biotherapeutics Appoints Mittie Doyle MD, FACR as Chief Medical Officer
Dr. Doyle brings more than 20 years of clinical development experience in industry and academia to Aro’s leadership team
Philadelphia, PA, October 7, 2021 – Aro...
Read more
Read more
October 6, 2021
Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer
Brussels, Belgium, 6 October 2021 – Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, announces that it has dosed the f...
Read more
Read more
October 5, 2021
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced t...
Read more
Read more
September 30, 2021
Targovax ASA appoints Ola Melin as Head of Manufacturing
Oslo, Norway, 30 September 2021 – Targovax ASA (OSE: TRVX) announces the appointment of Ola Melin as Head of Manufacturing. He will take a leading role in driving...
Read more
Read more
September 28, 2021
Fusion Pharmaceuticals Appoints Mohit Rawat As President And Chief Business Officer
HAMILTON, ON and BOSTON, Sept. 28, 2021 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developin...
Read more
Read more
September 28, 2021
BONESUPPORT – SUPPLEMENTARY US DENOVO APPLICATION SUBMITTED
Lund, Sweden, 08:00 CET, 28-09-21 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has submitted...
Read more
Read more